GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
D

DarioHealth DRIO · USD

Health Care · US listing · 🇺🇸 United States

Compare

1.32

-8.33%

Close of 20 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

DarioHealth — daily DRIO Delayed
Market value
$8.9m
Last close × shares
Volume
28.2k
Shares, 20 Nov 2026

About DarioHealth

From its filings with the US Securities and Exchange Commission

SEC filings

DarioHealth is based in New York, New York and is incorporated in Delaware. Its shares trade on Nasdaq under the ticker DRIO. The SEC classifies its business as surgical & medical instruments & apparatus. In the fiscal year to 31 December 2025, it reported revenue of $22.4m and a net loss of $41.7m. At that date it held total assets of $110.1m and shareholders' equity of $67.9m.

In its own words

We are a vertically integrated health intelligence platform with a mission to power the behavior changes that drive better health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, AI built on that proprietary data, and a behavior change and coaching layer validated through over 100 peer-reviewed clinical studies. We are committed to transforming healthcare by delivering a comprehensive and highly engaging whole-person health platform, which enables us to create a future where healthy change is effortless and accessible to all.

At the core of our mission and vision is engagement. We believe that most existing digital health solutions in the market fail to deliver improved health outcomes because users are not engaged due to a lack relevance, personalization, consumerization, and longitudinal data and information. We, and our acquired companies, first commercialized our digital behavioral health products in the direct-to-consumer (“D2C”) marketplace, and we continue to use the D2C marketplace as a sandbox and laboratory to innovation. These consumers pay for these digital health products out of their own pockets and are therefore the most value driven among all healthcare consumers. These consumers demanded that we deliver highly engaging user experiences that deliver strong clinical health outcomes for which consumers will pay.

Quoted from its 10-K, filed 19 Mar 2026. Read the filing on SEC.gov ↗

More about DarioHealth →

Latest on DarioHealth

Our reporting

Next results

18 Mar 2027

Due on 18 Mar 2027. Analysts expect earnings of -0.71 a share.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is DarioHealth's ticker?

DarioHealth trades as DRIO on its US listing, under ISIN US23725P3082.

What was DarioHealth's last closing price?

1.32 on 20 Nov 2026. The figure is in USD and is never converted.

When does DarioHealth next report results?

Results are expected on 12 Nov 2026, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
SEC filings and our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.